全文获取类型
收费全文 | 24984篇 |
免费 | 1749篇 |
国内免费 | 210篇 |
专业分类
耳鼻咽喉 | 484篇 |
儿科学 | 398篇 |
妇产科学 | 455篇 |
基础医学 | 3538篇 |
口腔科学 | 577篇 |
临床医学 | 2161篇 |
内科学 | 5142篇 |
皮肤病学 | 710篇 |
神经病学 | 1599篇 |
特种医学 | 1360篇 |
外科学 | 3298篇 |
综合类 | 787篇 |
现状与发展 | 1篇 |
一般理论 | 14篇 |
预防医学 | 1178篇 |
眼科学 | 840篇 |
药学 | 2044篇 |
中国医学 | 253篇 |
肿瘤学 | 2104篇 |
出版年
2023年 | 182篇 |
2022年 | 402篇 |
2021年 | 949篇 |
2020年 | 512篇 |
2019年 | 681篇 |
2018年 | 823篇 |
2017年 | 618篇 |
2016年 | 810篇 |
2015年 | 1076篇 |
2014年 | 1272篇 |
2013年 | 1354篇 |
2012年 | 2145篇 |
2011年 | 2054篇 |
2010年 | 1167篇 |
2009年 | 1042篇 |
2008年 | 1478篇 |
2007年 | 1407篇 |
2006年 | 1335篇 |
2005年 | 1261篇 |
2004年 | 987篇 |
2003年 | 829篇 |
2002年 | 653篇 |
2001年 | 536篇 |
2000年 | 516篇 |
1999年 | 421篇 |
1998年 | 153篇 |
1997年 | 125篇 |
1996年 | 83篇 |
1995年 | 89篇 |
1994年 | 87篇 |
1993年 | 71篇 |
1992年 | 162篇 |
1991年 | 173篇 |
1990年 | 140篇 |
1989年 | 133篇 |
1988年 | 119篇 |
1987年 | 140篇 |
1986年 | 108篇 |
1985年 | 99篇 |
1984年 | 74篇 |
1983年 | 71篇 |
1982年 | 39篇 |
1979年 | 62篇 |
1977年 | 39篇 |
1975年 | 38篇 |
1974年 | 39篇 |
1973年 | 36篇 |
1972年 | 37篇 |
1970年 | 35篇 |
1969年 | 40篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
Jin Gu Yoon Kyungmin Huh You Min Sohn Hyo Jung Park Soo Jin Na Kyeongman Jeon 《Journal of thoracic disease》2021,13(2):768
BackgroundVancomycin is the treatment of choice for serious methicillin-resistant Staphylococcus aureus (MRSA) infections. Current guidelines recommend giving an initial loading dose (LD) of 25–30 mg/kg to rapidly increase the serum concentration. However, high-quality evidence for the clinical benefit of LD is lacking. Herein, we aim to examine the association between vancomycin LD and clinical outcome.MethodsA retrospective cohort study was conducted on adult patients treated for MRSA pneumonia with vancomycin in medical intensive care units from April 2016 to August 2018. MRSA pneumonia was defined by the Centers for Disease Control and National Healthcare Safety Network definition. The primary outcome was the clinical cure of pneumonia. Secondary outcome measures included time to pharmacokinetic (PK) target attainment, microbiological cure, acute kidney injury, and all-cause mortality.ResultsA total of 81 patients were included; of these 22 (27.2%) received LD. The mean initial dose was significantly higher in the LD group. Clinical cure was similar in both groups (68.2% vs. 66.1% in the LD and non-LD groups, respectively; P=0.860). No significant difference was observed in the microbiological cure, all-cause mortality, and incidence of acute kidney injury. Furthermore, no difference was observed in terms of time to PK target attainment (69.2 vs. 63.4 h in the LD and non-LD groups, respectively; P=0.624). Vancomycin minimum inhibitory concentration of <2 mg/L was identified as an independent predictive factor for clinical cure in multivariable analysis, whereas vancomycin LD was not.ConclusionsInitial LD is not associated with better clinical outcome or rapid pharmacological target attainment in critically ill patients with MRSA pneumonia. Further studies are warranted to provide better evidence for this widely recommended practice. 相似文献
942.
Seong Mi Moon Jun Hyeok Lim Yun Soo Hong Kyeong-Cheol Shin Chang Youl Lee Do Jin Kim Sang Haak Lee Ki Suck Jung Chang-Hoon Lee Kwang Ha Yoo Hyun Lee Hye Yun Park 《Journal of thoracic disease》2021,13(2):837
BackgroundForced vital capacity (FVC) has been suggested to be a good biomarker for decreased exercise performance in patients with chronic obstructive pulmonary disease (COPD). However, as FVC is highly correlated with forced expiratory volume in 1 second (FEV1), the relationship between FVC and exercise capacity should be assessed within the category of FEV1, i.e., COPD severity. However, this was not considered in previous studies. Thus, limited data are available on the association between reduced FVC and exercise capacity measured by 6-min walk distance (6MWD) based on COPD severity.MethodsWe performed a cross-sectional study using data from the Korean COPD Subgroup Study (KOCOSS) cohort. We evaluated 1,386 patients with moderate (n=895) and severe-to-very severe (n=491) COPD. Reduced FVC was defined as FVC <80% predicted and short 6MWD as <350 m. Multivariable logistic regression was used to evaluate the association between reduced FVC and short 6MWD.ResultsThere were no significant differences in respiratory symptoms and quality of life between the patients with reduced FVC and those with preserved FVC. However, patients with reduced FVC had shorter 6MWD (30.5 cm in moderate and 34.5 cm in severe-to-very severe COPD) and higher BODE index scores than those with preserved FVC. The cubic spline model revealed 6MWD peaked around 93% predicted of FVC in moderate COPD, whereas FVC showed a positive association with 6MWD in severe-to-very severe COPD. Multivariable analyses showed that reduced FVC was significantly associated with short 6MWD in both moderate [adjusted odds ratio (aOR) =1.44, 95% confidence interval (CI): 1.03–2.02] and severe-to-very severe (adjusted OR =1.55, 95% CI: 1.01–2.40) COPD.ConclusionsReduced FVC was significantly associated with shorter 6MWD in moderate-to-very severe COPD patients, suggesting that reduced FVC might be reflective of 6MWD-measured exercise capacity in moderate-to-very severe COPD. 相似文献
943.
Han Sol Kang So Hyeon Bak Ha Yeun Oh Myoung-Nam Lim Yoon Ki Cha Hyun Jung Yoon Woo Jin Kim 《Journal of thoracic disease》2021,13(3):1495
BackgroundChronic obstructive pulmonary disease (COPD) has variable subtypes involving mixture of large airway inflammation, small airway disease, and emphysema. This study evaluated the relationship between visually assessed computed tomography (CT) subtypes and clinical/imaging characteristics.MethodsIn total, 452 participants were enrolled in this study between 2012 and 2017. Seven subtypes were defined by visual evaluation of CT images using Fleischner Society classification: normal, paraseptal emphysema (PSE), bronchial disease, and centrilobular emphysema (trace, mild, moderate and confluent/advanced destructive). The differences in several variables, including clinical, laboratory, spirometric, and quantitative CT features among CT-based visual subtypes, were compared using the chi-square tests and one-way analysis of variance.ResultsSubjects who had PSE had better forced expiratory volume in 1 second (FEV1) (P=0.03) percentage and higher lung density (P<0.05) than those with moderate to confluent/advanced destructive centrilobular emphysema. As the visual grade of centrilobular emphysema worsened, pulmonary function declined and modified Medical Research Council, COPD assessment test (CAT) score, and quantitative assessment (emphysema index and air trapping) increased. The bronchial subtype was associated with higher body mass index (BMI), better lung function and higher lung density. Participants with trace emphysema showed a rapid increase in functional small airway diseaseConclusionsClassifying subtypes using visual CT imaging features can reflect heterogeneity and pathological processes of COPD. 相似文献
944.
Proietti Riccardo Dowd Rory Gee Lim Ven Yusuf Shamil Panikker Sandeep Hayat Sajad Osman Faizel Patel Kiran Salim Handi Aldhoon Bashar Foster Will Merghani Ahmed Kuehl Michael Banerjee Prithwish Lellouche Nicolas Dhanjal Tarvinder 《Journal of interventional cardiac electrophysiology》2021,62(3):519-529
Journal of Interventional Cardiac Electrophysiology - Substrate mapping has highlighted the importance of targeting diastolic conduction channels and late potentials during ventricular tachycardia... 相似文献
945.
946.
Jose Paulo P. Lorenzo Ma. Hanna Monica Z. Sollano Evelyn O. Salido Julie Li-Yu Sandra A. Tankeh-Torres Ida Ayu Ratih Wulansari Manuaba Md Mujibur Rahman Binoy J. Paul Mo Yin Mok Monika De Silva Prasanta Padhan Ai Lee Lim Melvin Marcial Jennifer Jeanne Vicera Syed Atiqul Haq Sami Salman Chiranthi K. Liyanage Helen I. Keen Cheng Yew Kuang James Cheng-Chung Wei Rakhma Yanti Hellmi Charlie E. Chan Worawit Louthrenoo 《International journal of rheumatic diseases》2022,25(1):7-20
947.
Nicha Wongjarupong Gabriela M. Negron-Ocasio Kristin C. Mara Kritika Prasai Mohamed A. Abdallah Keun Soo Ahn Ju Dong Yang Benyam D. Addissie Nasra H. Giama William S. Harmsen Terry M. Therneau Lewis R. Roberts 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2021,23(5):762-769
BackgroundThe BALAD score and BALAD-2 class derived from bilirubin, albumin, AFP, AFP-L3, and des-gamma-carboxyprothrombin (DCP) are effective in predicting mortality in HCC, but have not been validated in North America.Methods148 HCC patients from 2000 to 2015 who had all five biomarkers tested at diagnosis were included. Hazard ratios (HR) were calculated.Results75 patients died during a median follow-up of 21.9 months. 1-and 3-year survival rates were 70.8% and 47.6%. 114 (77%) had cirrhosis. The HR (95%CI) for death were 1.24 (0.42–3.67), 1.79 (0.61–5.26), 2.83 (0.95–8.38), and 7.19 (2.26–22.91) for BALAD scores 1, 2, 3, and 4 vs. BALAD 0. The HR (95%CI) for death were 1.25 (0.65–2.40), 1.75 (0.94–3.23), and 6.20 (3.29–11.68) for BALAD-2 classes 2, 3, and 4 vs. BALAD-2 class 1. A multivariate model incorporating maximal tumor diameter, tumor number, neutrophil-lymphocyte ratio, and BALAD had HR of 1.43 (1.14–1.81) per increase of 1 BALAD score. A similar model with BALAD-2 had HR of 1.50 (1.18–1.90) per increase of 1 BALAD-2 class.ConclusionBALAD models at diagnosis can predict the survival of HCC patients in North America. AFP, AFP-L3, and DCP reflect tumor progression and metastasis of HCC and distinguish the BALAD model from other predictive models. 相似文献
948.
D. Scott Lim MD Robert L. Smith MD Firas Zahr MD Abhijeet Dhoble MD Roger Laham MD Mohamad Lazkani MD Susheel Kodali MD Chad Kliger MD James Hermiller MD Amit Vora MD Ian J. Sarembock MB ChB MD William Gray MD Samir Kapadia MD Adam Greenbaum MD Andrew Rassi MD David Lee MD Adnan Chhatriwalla MD Pinak Shah MD Josep Rodés-Cabau MD Homam Ibrahim MD Lowell Satler MD Howard C. Herrmann MD Paul Mahoney MD Charles Davidson MD George Petrossian MD Mayra Guerrero MD Konstantinos Koulogiannis MD Leo Marcoff MD Linda Gillam MD The CLASP IID Pivotal Trial Investigators 《Catheterization and cardiovascular interventions》2021,98(4):E637-E646
949.
950.
Dong Wook Choi Man Sup Lim Jae Won Lee Wanjoo Chun Sang Hyuk Lee Yang Hoon Nam Jin Myung Park Dae Hee Choi Chang Don Kang Sung Joon Lee Sung Chul Park 《Biomolecules & therapeutics.》2015,23(2):128-133
Although coffee is known to have antioxidant, anti-inflammatory, and antitumor properties, there have been few reports about the effect and mechanism of coffee compounds in colorectal cancer. Heat shock proteins (HSPs) are molecular chaperones that prevent cell death. Their expression is significantly elevated in many tumors and is accompanied by increased cell proliferation, metastasis and poor response to chemotherapy. In this study, we investigated the cytotoxicity of four bioactive compounds in coffee, namely, caffeine, caffeic acid, chlorogenic acid, and kahweol, in HT-29 human colon adenocarcinoma cells. Only kahweol showed significant cytotoxicity. Specifically, kahweol increased the expression of caspase-3, a pro-apoptotic factor, and decreased the expression of anti-apoptotic factors, such as Bcl-2 and phosphorylated Akt. In addition, kahweol significantly attenuated the expression of HSP70. Inhibition of HSP70 activity with triptolide increased kahweol-induced cytotoxicity. In contrast, overexpression of HSP70 significantly reduced kahweol-induced cell death. Taken together, these results demonstrate that kahweol inhibits colorectal tumor cell growth by promoting apoptosis and suppressing HSP70 expression. 相似文献